Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
02/10/2026 22:10
BRIEF-Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing Oct 2 (Reuters) - Silo Pharma Inc SILO.O:
SILO PHARMA - ENTERS ASSET PURCHASE AGREEMENT WITH NORSIGHT CONSULTING ON OCT 1, 2026 - SEC FILING
SILO PHARMA - TO BUY SOFTWARE AND INTELLECTUAL PROPERTY FROM NORSIGHT CONSULTING - SEC FILING
Source text: [ID:n0001213900-26-106435]
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement